YCYogini V. Chudasama

Yogini V. Chudasama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yogini V. Chudasama has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Increasing burden of multiple long-term conditions and mortality risk following COVID-19 diagnosis: a national cohort study of one million adults with cardiovascular disease in England

    by Yogini V Chudasama, Sharmin Shabnam, Kamlesh Khunti, Cameron Razieh, Clare L Gillies, Nazrul Islam, Thomas Yates, Amitava Banerjee, Nathalie Conrad, Spiros Denaxas, et al.

    Background: Individuals with cardiovascular disease (CVD) experienced high mortality during coronavirus disease 2019 (COVID-19), yet most live with multiple long-term conditions (MLTCs). We examined the association between MLTCs burden and mortality following COVID-19 among people with CVD. Methods: In this population-based cohort study, linked national electronic health records from England were analysed. Adults aged ≥18 years with CVD and a positive COVID-19 test between 31 January 2020 and 31 October 2022 were included. MLTCs burden was defined as the number of additional long-term conditions beyond CVD (0, 1, 2, or ≥3). One-year mortality was assessed using adjusted flexible parametric Royston–Parmar models. Results: In 1 081 695 individuals with CVD and COVID-19, 89.7% had at least one long-term condition (LTC) and 67.9% had two or more. Increasing MLTC burden showed a dose–response association with mortality. Compared to individuals without additional LTCs, mortality risk was doubled for those with one LTC (adjusted hazard ratio: 1.86, 95% CI: 1.76–1.96), tripled among those with two LTCs (3.00, 2.85–3.16), and five-fold higher in those with ≥3 LTCs (5.00, 4.75–5.27). Associations were consistent across CVD subtypes. Conclusions: MLTCs burden was a stronger determinant of mortality risk than CVD subtype alone. Findings support moving beyond single-disease models towards integrated, MLTC-informed care, and pandemic preparedness.

  • Open Access

    Variations in the Risk of New‐Onset Diabetes Following COVID ‐19 Infection Across Body Mass Index, Deprivation, Ethnicity and Geographic Regions: Population‐Based Cohort Study in 42 Million People in England

    by Sharmin Shabnam, Cameron Razieh, John Nolan, Nazrul Islam, Genevieve Cezard, Yogini V. Chudasama, Clare L. Gillies, Amitava Banerjee, Angela Wood, Kamlesh Khunti, et al.

    Aims: Evidence suggests that COVID‐19 may be associated with an increased risk of diabetes. We aimed to examine this association by investigating the role of socioeconomic and metabolic factors on the risk of new‐onset type 2 (T2D) and type 1 (T1D) diabetes after COVID‐19 diagnosis. Materials and Methods: We conducted a retrospective, population‐based cohort study using linked electronic health records from NHS England's Secure Data Environment for England via the CVD‐COVID‐UK/COVID‐IMPACT consortium. Adults (≥ 18 years), alive, registered with a general practice within 1 January 2020 and 28 May 2024 were included. Exposed individuals with confirmed COVID‐19 diagnosis and no prior diabetes were matched to up to three unexposed individuals without COVID‐19 and diabetes on age, sex, region and deprivation. Flexible parametric survival models were used to estimate associations between COVID‐19 and incident diabetes by sex and across age, BMI, deprivation, ethnicity, and region. Results: Of 50 156 810 eligible individuals, 12 859 545 with a COVID‐19 diagnosis and no prior diabetes were matched to 29 221 285 without COVID‐19; the median follow‐up was 2.4 years. Although BMI was strongly and positively associated with the risk of T2D, differences between exposed and unexposed individuals were little to none, with the excess risk concentrated in the first year (e.g., in 70‐year‐old men with BMI 35 kg/m 2 , rates were 44.2 [95% CI: 43.6–44.8] and 44.2 [43.7–44.8] per 1000 person‐years in the exposed and unexposed group, respectively, at 1 year; corresponding figures in women were 28.0 [27.6–28.5] and 29.1 [28.7–29.5]). These rate differences by COVID‐19 exposure were considerably smaller than those across BMI levels: for example, 22 more T2D cases per 1000 person‐years at 1 year for those with a BMI of 35 versus 30 kg/m 2 in unexposed 70‐year‐old men. Similarly, higher deprivation and Asian ethnicity were also more strongly associated with the risk of T2D than COVID‐19 exposure. There was no evidence of an association between COVID‐19 and T1D across all analyses. Conclusions: In this cohort, COVID‐19 was associated with a modest, short‐term increase in T2D risk and showed no meaningful association with T1D. Established metabolic, demographic and socioeconomic factors—including age, BMI, deprivation and ethnicity—were more strongly associated with T2D incidence than COVID‐19 exposure.

  • Open Access

    Health outcome priorities of people with multiple long-term conditions before and during the COVID-19 pandemic: Survey data from the UK

    by Harini Sathanapally, Yogini V Chudasama, Francesco Zaccardi, Alessandro Rizzi, Samuel Seidu, Kamlesh Khunti

    Background The outcome prioritisation tool (OPT) is a simple tool to ascertain the health outcome priorities of people with MLTC. Use of this tool in people aged under 65 years with MLTC has not previously been investigated. This study investigated the feasibility of using the OPT in people with MLTC aged 45 years or above, in a multi-ethnic primary-care setting, to describe the health outcome priorities of people with MLTC by age, clusters of long-term conditions and demographic factors, and to investigate any differences in prioritisation in light of the COVID-19 pandemic. Methods This was a multi-centre cross-sectional study using a questionnaire for online self-completion by people aged 45 years or above with MLTC in 19 primary care settings across the East Midlands, UK. Participants were asked to complete the OPT twice, first from their current perspective and second from their recollection of their priorities prior to COVID-19. Results The questionnaire was completed by 2,454 people with MLTC. The majority of participants agreed or strongly agreed that the OPT was easy to complete, relevant to their healthcare and will be useful in communicating priorities to their doctor. Summary scores for the whole cohort of participants showed Keeping Alive and Maintaining Independence receiving the highest scores. Statistically significant differences in prioritisation by age, clusters of long-term conditions and employment status were observed, with respondents aged over 65 most likely to prioritise Maintaining independence, and respondents aged under 65 most likely to prioritise Keeping alive. There were no differences before or after COVID-19, or by ethnicity. Conclusions The OPT is feasible and acceptable for use to elicit the health outcome priorities of people with MLTC across both middle-aged and older age groups and in a UK setting. Individual factors could influence the priorities of people with MLTC and must be considered by clinicians during consultations. HIGHLIGHTS Survey data from 2,454 patients with MLTC showed that keeping alive and maintaining independence were the top first-choice priorities from the health outcome priorities tool (OPT). The health outcomes priorities differed by socio-demographics and clusters of long-term conditions. There were no differences in health outcomes priorities before and during COVID-19. OPT is easy and acceptable to implement in a health care setting in a broad patient group. Translation of the OPT into different languages is recommended to address any potential language barrier for people with MLTC completing the OPT

  • Open Access

    Health and social care experience and research perception of different ethnic minority populations in the East Midlands, United Kingdom (REPRESENT study)

    by Winifred Ekezie, Shabana Cassambai, Barbara Czyznikowska, Ffion Curtis, Lauren L. O'MAhoney, Andrew Willis, Yogini Chudasama, Kamlesh Khunti, Azhar Farooqi

    Introduction: Ethnic minority populations experience significant health and social care disparities; despite experiencing a greater burden of diseases, these groups are underrepresented in health and social care research. Consequently, related research can be less applicable to these population groups. The REPRESENT study aims to explore the health and social care experiences of ethnic minorities and other minoritised populations, their research interests and appropriate research practices.Methods: Focus groups and semistructured interviews were conducted between May and September 2022 with members of a number of ethnic minority communities in England. Data were audio recorded, transcribed and thematically coded using NVivo 12. Rigour was determined through extensive sampling, iterative data collection and analysis.Findings: Fifty‐two ethnic minority members were engaged in group interviews and one‐to‐one interviews. Participants included representatives of the following groups: African Caribbean, Eastern European, Gypsy Travellers, Lesbian, Gay, Bisexual, Transgender, Queer, Intersex and Asexual+, Refugee/Asylum Seekers, Somali and South Asian communities. Interviews were also conducted with ethnic minority healthcare providers and researchers. Three overarching categories were identified: health information, medical service experiences, health and social care concerns and health research. Health and social care services challenges were mostly attributed to discrimination, delayed services, poor cultural relevance and language and cultural barriers. The most influential information sources were local community organisations and word‐of‐mouth. The main health and social care concerns were chronic long‐term health conditions, mental health, maternal health and child development. Recommendations for research involved understanding the motivations for participation, improving communication and empowering communities. Top research priorities were long‐term health conditions, health promotion and education, early care interventions and understanding community needs.Interpretation: Discrimination and bias in health and social care provision have severe implications for worsening ethnic health inequalities. Healthcare commissioning authorities and policymakers can leverage the preference of ethnic minority groups for pharmacy services and community organisations to improve access to care. Improving research interest and engagement requires understanding individual community needs, community sensitivity, research relevance and cultural appropriateness.Patient or Public Contribution: Members of ethnic minority Patient and Public Involvement and Engagement group and Community Advisory Board supported the REPRESENT study design, conceptualisation and report development.


  • Top Cited Papers
    Open Access

    Diabetes and Multiple Long-term Conditions: A Review of Our Current Global Health Challenge

    by Kamlesh Khunti, Yogini V. Chudasama, Edward W. Gregg, Monika Kamkuemah, Shivani Misra, Jerry Suls, Nikhil S. Venkateshmurthy, Jonathan Valabhji

    Use of effective treatments and management programs is leading to longer survival of people with diabetes. This, in combination with obesity, is thus contributing to a rise in people living with more than one condition, known as multiple long-term conditions (MLTC or multimorbidity). MLTC is defined as the presence of two or more long-term conditions, with possible combinations of physical, infectious, or mental health conditions, where no one condition is considered as the index. These include a range of conditions such as cardiovascular diseases, cancer, chronic kidney disease, arthritis, depression, dementia, and severe mental health illnesses. MLTC has major implications for the individual such as poor quality of life, worse health outcomes, fragmented care, polypharmacy, poor treatment adherence, mortality, and a significant impact on health care services. MLTC is a challenge, where interventions for prevention and management are lacking a robust evidence base. The key research directions for diabetes and MLTC from a global perspective include system delivery and care coordination, lifestyle interventions and therapeutic interventions.


  • Open Access

    Life expectancy following a cardiovascular event in individuals with and without type 2 diabetes: A UK multi-ethnic population-based observational study

    by Yogini V. Chudasama, Kamlesh Khunti, Briana Coles, Clare L. Gillies, Nazrul Islam, Alex V. Rowlands, Samuel Seidu, Cameron Razieh, Melanie J. Davies, Nilesh J. Samani, et al.


  • Open Access

    Healthy lifestyle choices and microvascular complications: New insights into diabetes management

    by Yogini V. Chudasama, Kamlesh Khunti

    Yogini Chudasama and Kamlesh Khunti discuss new evidence, published in PLOS Medicine, highlighting the importance of healthy lifestyle behaviours in diabetes management.


  • Open Access

    Estimates of years of life lost depended on the method used: tutorial and comparative investigation

    by Yogini V. Chudasama, Kamlesh Khunti, Clare L. Gillies, Nafeesa N. Dhalwani, Melanie J. Davies, Thomas Yates, Francesco Zaccardi


  • The effectiveness of a structured group education programme for people with established type 2 diabetes in a multi-ethnic population in primary care: A cluster randomised trial

    by Helen Dallosso, Panna Mandalia, Laura J. Gray, Yogini V. Chudasama, Sopna Choudhury, Shahrad Taheri, Naina Patel, Kamlesh Khunti, Melanie J. Davies